U
INSM icon

UBS’s Insmed INSM Stock Holding History

UBS’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,500
Closed -$29K – 10605
2014
Q1 		$29K Buy
+1,500
New +$28.5K ﹤0.01% 7587
2013
Q4 		– Sell
-500
Closed -$8K – 10553
2013
Q3 		$8K Sell
500
-700
-58% -$8.89K ﹤0.01% 9015
2013
Q2 		$14K Buy
+1,200
New +$12.3K ﹤0.01% 8271

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

UBS's INSM Position: Q3 2014 in Review

UBS increased its Insmed (INSM) stake by 195% in Q3 2014, buying an estimated $9.04M and bringing the position to 907,496 shares worth $11.8M. The position accounts for 0.01% of the portfolio, ranked #1318.

UBS first reported a position in INSM in Q2 2013 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold INSM as of Q3 2014.

  • UBS held 907,496 shares of Insmed worth $11.8M as of Q3 2014.
  • UBS bought 599,564 Insmed shares in Q3 2014, an estimated $9.04M.
  • Insmed made up 0.01% of UBS's portfolio in Q3 2014, its #1318 holding.
  • UBS first reported a position in Insmed in Q2 2013 and has held it in 6 quarters since.
  • 102 funds tracked by Wall St. Rank held Insmed as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.